Patents by Inventor Steven Richard Blumberg

Steven Richard Blumberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of agents derived from CEACAM1 for the treatment of inflammatory diseases
    Publication number: 20110189181
    Abstract: The use of an agent that selectively modulates cross-linking of biliary glycoprotein polypeptides for the preparation of a pharmaceutical composition for preventing or treatment of a mammal subject afflicted with an inflammatory disease is provided. In particular, a method for preventing or treatment of a mammal subject afflicted with rheumatoid arthritis or multiple sclerosis, comprising the step of administering to a mammal in need thereof a therapeutic effective amount of a fusion protein of a fragment of biliary glycoprotein and a fragment of an immunoglobulin is described.
    Type: Application
    Filed: August 2, 2010
    Publication date: August 4, 2011
    Inventors: Nalan Utku, Steven Richard Blumberg
  • Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases
    Publication number: 20080026980
    Abstract: The use of an agent that selectively modulates cross-linking of biliary glycoprotein polypeptides for the preparation of a pharmaceutical composition for preventing or treatment of a mammal subject afflicted with an inflammatory disease is provided. In particular, a method for preventing or treatment of a mammal subject afflicted with rheumatoid arthritis or multiple sclerosis, comprising the step of administering to a mammal in need thereof a therapeutic effective amount of a fusion protein of a fragment of biliary glycoprotein and a fragment of an immunoglobulin is described.
    Type: Application
    Filed: December 17, 2004
    Publication date: January 31, 2008
    Inventors: Nalan Utku, Steven Richard Blumberg